New Next 10 Report Examines 20 Years of California Climate Progress Under AB 32
Image File
Original HTML

Analysis finds landmark law helped cut emissions, grow the economy and deliver billions in economic benefits, while identifying affordability as critical to sustaining future progress

SACRAMENTO, Calif., Sept. 25, 2026 /PRNewswire/ -- Twenty years after California adopted its landmark climate law, a new report from Next 10 examines how Assembly Bill 32 transformed the state's economy and energy system, accelerated investment in clean technology and established California as a global leader in climate action.

The report, Twenty Years of AB 32: California's Landmark Climate Law and Its Legacy, finds that California reduced statewide greenhouse gas emissions by 23.3% between 2006 and 2023 while continuing to grow its economy. During that period, gross domestic product per capita increased by 41%, while greenhouse gas emissions per capita fell by 29%.

"California's experience over the last 20 years demonstrates that reducing emissions and growing the economy are not mutually exclusive," said F. Noel Perry, founder of Next 10. "AB 32 helped create an entirely new framework for climate action—one that has driven innovation, attracted investment, created jobs, and delivered measurable benefits to communities throughout the state."

Signed into law in 2006 by Governor Arnold Schwarzenegger, AB 32 established the nation's first economy-wide cap on greenhouse gas emissions and laid the foundation for California's cap-and-trade program, now known as Cap-and-Invest. Revenue generated by the program has supported investments in affordable housing, clean transportation, energy efficiency, air quality, safe drinking water, and climate resilience. These programs have also put money back into Californians' pocketbooks through utility-bill credits, rebates and incentives that help lower household energy and transportation costs.

"The story of AB 32 is the type of policy story the world needs right now. It's a story of what is possible when leaders have the courage to think big, work together across partisan divides, and terminate pollution," said former Governor Arnold Schwarzenegger. "California didn't wait for anybody else. We did what was right, by working as a team, in an election year, to show the world that the idea that we had to choose between protecting the environment and growing the economy was a false choice."

Over the next two decades, AB 32 provided the foundation for continued climate action across three gubernatorial administrations, working with the Legislature, the California Air Resources Board, the California Energy Commission, and other state agencies to deliver environmental, economic and public health benefits across California.

Among the report's key findings:

Economic Benefits

- California's Gross Domestic Product (GDP) per capita grew by 41% between 2006 and 2023.

- California led the nation with 552,300 clean-energy jobs in 2024, nearly twice as many as the second-ranked state, Texas.

- Of the $15.5 billion implemented through California Climate Investments between 2014 and 2025, 76% benefited disadvantaged and low-income communities and households.

- More than $16 billion has been returned to residents and small businesses through twice-yearly California Climate Credits on electricity and natural-gas bills.

- California Climate Investments have reduced energy and fuel-use costs by an estimated $38.1 billion, including $5.2 billion in 2024.

- Climate-funded projects are expected to generate $44 billion in savings from reduced energy and transportation expenses, including fuel and parking costs, over the project lifetimes.

- Since the 1970s, California's energy-efficiency standards have saved consumers more than $200 billion, while the 2025 California Energy Code is projected to save an additional $4.8 billion over 30 years.

- The Affordable Housing and Sustainable Communities Program has helped build 20,361 affordable homes, with residents saving an average of $10,566 per household annually in rent.

Environmental Benefits

- Statewide greenhouse gas emissions fell by 23.3% between 2006 and 2023, while emissions per capita fell by 29%.

- California met its initial goal of reducing emissions to 1990 levels four years ahead of schedule.

- Transportation-sector emissions fell by 26.7% between 2006 and 2023, including reductions of 19.7% from passenger vehicles and 45.3% from heavy-duty vehicles.

- Emissions from electricity generation fell by 45.2% between 2006 and 2023, including a 70.9% reduction from imported electricity and a 17.4% reduction from in-state generation.

- Utility-scale and rooftop solar supplied 51% of California's electricity in May 2026, making California the first major economy in the world to generate more than half of its electricity from solar for a full month.

- California installed more than 21,000 megawatts of battery storage by mid-2026, a 2,500% increase since 2019 and 41% of the way toward the state's 2045 target.

"AB 32 sent a clear signal that California was serious about building a clean-energy economy," said Matt Petersen, president and CEO of the Los Angeles Cleantech Incubator. "We have seen that leadership help entrepreneurs turn new ideas into companies, attract private investment and build a thriving innovation economy that creates jobs and opportunity."

The report calls for continued investment and policy innovation to meet growing electricity demand, modernize aging infrastructure and reduce emissions without placing new costs on consumers. It identifies energy efficiency, more cost-effective wildfire mitigation, clean-energy development, grid modernization, and targeted incentives as important tools that support affordability while keeping California on course toward its climate goals.

"The next chapter of California climate policy must be judged not only by how effectively it reduces emissions, but also by whether it makes the transition more affordable and accessible," Perry said. "That means lowering household costs, protecting ratepayers and ensuring that low- and middle-income Californians can participate fully in—and benefit from—the state's clean-energy future."

The full report is available here.

About Next 10

Next 10 is an independent, nonpartisan organization that educates, engages and empowers Californians to improve the state's future. Next 10 commissions research from leading experts on complex state issues and communicates the findings to help inform California's most important policy debates.

SOURCE Next 10

Share this article

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
prn_302890355
Press Eligible
Yes
Press Eligible Reason
Report on California climate policy, economic growth, clean-energy investment, jobs, emissions, and infrastructure.
Source Name
Unknown Company
Original Summary

<p>Analysis finds landmark law helped cut emissions, grow the economy and deliver billions in economic benefits, while identifying affordability as critical to sustaining future progress SACRAMENTO, Calif., Sept. 25, 2026 /PRNewswire/ -- Twenty years after California adopted its landmark...</p>

Image URL
https://mmx.prnewswire.com/media/MS1996320/Next-10-logo-LARGE.jpg?id=OA2970735&p=facebook
Content Hash (SHA-256, erste 32 hex)
1f1c1728c586769bb89142b96fcab868
Ardagh Group S.A. Q3 2026 Results and Investor Call Notification
Image File
Original HTML

LUXEMBOURG, Sept. 25, 2026 /PRNewswire/ -- Ardagh Group S.A. will host its Third Quarter 2026 investor call on Thursday, October 22, 2026.

An interim report will be posted to our website at midday BST (07:00 EDT) on October 22, 2026, at: https://ir.ardaghgroup.com/

An investor webcast and conference call will be held at 16:00 BST (11:00 EDT) on October 22, 2026. A full replay of the presentation will also be available at the same link shortly after the conclusion of the live presentation.

Webcast https://event.webcasts.com/starthere.jsp?ei=1777078&tp_key=54c16c3d0f

Dial in*:

International: +44 (0)20 7769 6464

US: +1 646-769-9200

Conference code: 5992209

*It is not necessary to dial into the audio conference unless you are unable to join the webcast.

Additional dial-in numbers are at this link, or simply click here to connect (globalmeet.com) and enter your details to be connected. The link is active 15 minutes prior to the start time.

About Ardagh Group

Ardagh Holdings S.A. is the ultimate parent company of Ardagh Group, which is a global supplier of infinitely recyclable metal and glass container packaging for brand owners around the world. Ardagh Group operates 58 metal and glass production facilities in 16 countries, employing approximately 20,000 people with sales of approximately $9.6 billion.

SOURCE Ardagh Group S.A.

Share this article

Ingest Status
Rejected
Dedupe hash
prn_302890387
Source Name
Unknown Company
Original Summary

<p>LUXEMBOURG, Sept. 25, 2026 /PRNewswire/ -- Ardagh Group S.A. will host its Third Quarter 2026 investor call on Thursday, October 22, 2026. An interim report will be posted to our website at midday BST (07:00 EDT) on October 22, 2026, at: https://ir.ardaghgroup.com/ An investor webcast and...</p>

Image URL
https://mmx.prnewswire.com/media/MS1761311/Ardagh-Group-Logo.jpg?id=OA2971425&p=facebook
Content Hash (SHA-256, erste 32 hex)
c6652348567feb96a9897b04d25a3085
Ardagh Metal Packaging S.A. Q3 2026 Results and Investor Call Notification
Image File
Original HTML

LUXEMBOURG, Sept. 25, 2026 /PRNewswire/ -- Ardagh Metal Packaging S.A. will host its Third Quarter 2026 earnings call on Thursday, October 22, 2026.

A results release will be posted to our website at midday BST (07:00 EDT) on October 22, 2026, at https://ir.ardaghmetalpackaging.com/

An investor webcast and conference call will be held at 14:00 BST (09:00 EDT) on October 22, 2026. A full replay of the presentation will also be available at the same link shortly after the conclusion of the live presentation.

Webcast https://event.webcasts.com/starthere.jsp?ei=1777075&tp_key=8448e3c5dc

 Dial in*:

International: +44 (0)20 7769-6464

US/Canada: +1 646 769-9200

Conference code: 4670396

*It is not necessary to dial into the audio conference unless you are unable to join the webcast.

Additional dial-in numbers are at this link, or simply click here to connect (globalmeet.com) and enter your details to be connected. The link is active 15 minutes prior to the start time.

About Ardagh Metal Packaging

Ardagh Metal Packaging (AMP) is a leading global supplier of sustainable and infinitely recyclable metal beverage cans to brand owners globally. An operating business of sustainable packaging business Ardagh Group, AMP is a leading industry player across Europe and the Americas with innovative production capabilities. AMP operates 23 production facilities in nine countries, employing approximately 6,500 people with sales of $5.5bn in 2025.

SOURCE Ardagh Metal Packaging S.A.

Share this article

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
prn_302890368
Press Eligible
Yes
Press Eligible Reason
QA FAIL (need review): Final paragraph is a generic 'About the Company' boilerplate copied from the source (e.g., 'Ardagh Metal Packaging, an operating business of Ardagh Group, supplies sustainable...'), adding no news context. This is not an acceptable ending per the PR-boilerplate rule.
Source Name
Unknown Company
Original Summary

<p>LUXEMBOURG, Sept. 25, 2026 /PRNewswire/ -- Ardagh Metal Packaging S.A. will host its Third Quarter 2026 earnings call on Thursday, October 22, 2026. A results release will be posted to our website at midday BST (07:00 EDT) on October 22, 2026, at https://ir.ardaghmetalpackaging.com/ An...</p>

Image URL
https://mmx.prnewswire.com/media/MS1757973/Ardagh-Metal-Packaging-Logo.jpg?id=OA2971423&p=facebook
Content Hash (SHA-256, erste 32 hex)
fff755ee569f928d9f102d65735e1f43
York Space Systems (YSS) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 30, 2026 Lead Plaintiff Deadline
Image File
Original HTML

SAN FRANCISCO, Sept. 25, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in York Space Systems, Inc. (NYSE: YSS) of the pending federal securities class action lawsuit and the upcoming October 30, 2026 lead plaintiff deadline.

The securities class action, pending in the U.S. District Court for the District of Colorado, covers:

- All persons and entities who purchased or otherwise acquired York common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's January 2026 initial public offering (IPO); and

- All persons and entities who purchased or otherwise acquired York securities between January 29, 2026, and May 11, 2026, inclusive (the "Class Period").

The firm urges investors who suffered substantial losses on investments in York Space securities to submit their losses now.

What is the YSS Securities Class Action About?

The class action lawsuit alleges that in its IPO materials and throughout the class period, York Space Systems and its senior leadership made materially false and misleading statements to investors and omitted material adverse facts regarding the company's satellite software development, operational readiness, and government defense contracts.

Specifically, the complaint alleges that defendants omitted to disclose:

- Pre-Launch Software Failures: That York's onboard mission and payload software was not fully functional before satellites were launched into orbit;

- Jeopardized Operations and Milestones: That persistent software deficiencies jeopardized satellite operations and contractually required delivery milestones;

- Undisclosed Risks to SDA Contracts: That this ongoing operational failure presented an undisclosed, acute risk to York's multi-hundred-million-dollar contracts with the U.S. Department of Defense's Space Development Agency (SDA), including critical Tranche 3 procurement funding; and

- Misleading Picture of Operations and Prospects: As a result, defendants' statements regarding York's manufacturing scale, technological reliability, and commercial backlog were materially false and misleading.

Hagens Berman's Investigation

Hagens Berman investigating whether the company misrepresented its pre-launch onboard mission and payload software functionality and concealed persistent software deficiencies, as the suit alleges.

"We are focused if and when York management knew about the allegedly undisclosed operational failures," said Reed Kathrein, partner at Hagens Berman.

What Can $YSS Investors Do:

If you purchased or otherwise acquired York Space Systems Inc. (NYSE: YSS) securities and suffered substantial losses, you have until October 30, 2026 to ask the Court to appoint you as Lead Plaintiff.

To discuss your legal rights, visit www.hbsslaw.com/yss or contact Reed Kathrein, who is leading the firm's investigation, by calling 844-916-0895 or emailing [email protected].

If you'd like more information and answers to frequently asked questions about the York Space Systems case and the firm's investigation, read more »

Whistleblowers: Persons with non-public information regarding York Space Systems should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

SOURCE Hagens Berman Sobol Shapiro LLP

Share this article

Class (B2B/B2C)
Ignore
Ingest Status
Need Review
Dedupe hash
prn_302890346
Press Eligible
No
Press Eligible Reason
Irrelevant (need review): Law firm securities fraud class action alert soliciting investors for legal action.
Source Name
York Space Systems (YSS) Investors
Original Summary

<p>SAN FRANCISCO, Sept. 25, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in York Space Systems, Inc. (NYSE: YSS) of the pending federal securities class action lawsuit and the upcoming October 30, 2026 lead plaintiff deadline. The securities class action, pending in...</p>

Image URL
https://mmx.prnewswire.com/media/MS1117217/Hagens-Berman-Sobol-Shapiro-LLP-Logo.jpg?id=OA2971246&p=facebook
Content Hash (SHA-256, erste 32 hex)
bd105a247292b6f132fc331740bcc606
Shadow AI Risk &amp; Governance Market worth $8.64 billion by 2032 - Exclusive Report by MarketsandMarkets™
Image File
Original HTML

DELRAY BEACH, Fla., Sept. 25, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Shadow AI Risk & Governance Market is projected to grow from USD 1.39 billion in 2026 to USD 8.64 billion by 2032 at a CAGR of 35.6% during the forecast period.

Browse 400 market data Tables and 50 Figures spread through 350 Pages and in-depth TOC on "Shadow AI Risk & Governance Market - Global Forecast to 2032"

Shadow AI Risk & Governance Market Size & Forecast:

- Market Size Available for Years: 2025–2032

- 2025 Market Size: USD 1.02 billion

- 2026 Market Size: USD 1.39 billion

- 2032 Projected Market Size: USD 8.64 billion

- CAGR (2026–2032): 35.6%

Shadow AI Risk & Governance Market Trends & Insights:

- A key growth driver is the rapid spread of AI tools beyond centrally managed enterprise environments.

- By offering, the solutions segment is estimated to dominate the market in 2026.

- By solution type, AI access & agent governance is set to grow at the fastest rate, registering a CAGR of 47.2%.

- By deployment mode, the cloud segment is projected to grow at a rapid pace, at the highest CAGR of 36.7%.

- North America is estimated to account for the highest share of 44.0% of the Shadow AI Risk & Governance Market in 2026.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40880961

Organizations are placing greater emphasis on documenting how AI applications are assessed, approved, monitored, and controlled, creating demand for technologies that can generate traceable evidence of governance activities. AI governance programs increasingly require records of risk assessments, policy decisions, control implementation, approvals, and monitoring outcomes rather than relying solely on written policies. This is creating demand for platforms that automate evidence collection, maintain audit trails, and provide centralized documentation across AI applications and governance processes. Recent industry research also indicates that organizations are moving toward more operationalized AI governance, increasing the need to connect governance activities with demonstrable controls and evidence.

Based on solution type, the AI data protection & security segment is expected to hold the largest market during the forecast period.

The AI data protection & security controls segment is supported by the need to secure sensitive enterprise information accessed and processed through AI applications. Organizations are deploying capabilities to identify sensitive data, monitor AI-related data flows, control information access, prevent unauthorized disclosure, and enforce data handling policies. Integration of AI applications with corporate databases, documents, SaaS platforms, and other enterprise repositories is increasing the need for stronger controls that protect confidential information while enabling legitimate AI use. Integration with existing data security and enterprise security infrastructure is also supporting adoption of these capabilities.

Request for Proposal: https://www.marketsandmarkets.com/requestsampleNew.asp?id=40880961

By organization size, the SMEs segment is expected to register the highest CAGR during the forecast period.

The SMEs segment is supported by the growing availability of cloud-based and modular AI governance technologies that require limited infrastructure and internal resources. Smaller organizations are adopting AI across functions such as customer service, marketing, software development, finance, and operations, creating requirements for practical controls around AI usage. Solutions that automate AI risk assessment, policy management, usage monitoring, compliance documentation, and security enforcement are helping organizations address these requirements with smaller technology and governance teams. Subscription-based platforms and integrated solutions are further lowering implementation complexity and enabling SMEs to expand governance capabilities as their use of AI increases.

By region, North America is estimated to account for the largest market share during the forecast period.

North America is expected to account for the largest share of the Shadow AI Risk & Governance Market, supported by its established cybersecurity ecosystem, concentration of AI technology providers, and continued development of practical frameworks for managing AI-related risks. In the US, NIST is expanding its AI risk-management work through updates to the AI Risk Management Framework, AI standards initiatives, and security-focused guidance covering generative AI and AI agent systems. NIST is also developing a Trustworthy AI in Critical Infrastructure Profile to provide sector-specific risk-management practices for organizations deploying AI-enabled capabilities. In Canada, government initiatives are advancing responsible AI through the national AI strategy, AI transparency measures, privacy modernization, and guidance for the responsible use of generative and agentic AI. These developments, alongside the presence of established cybersecurity and AI governance providers, are supporting demand for AI discovery, data protection, policy management, risk assessment, and access controls across enterprises in the region.

Request Pricing: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=40880961

Top Companies in Shadow AI Risk & Governance Market:

The Top Companies in Shadow AI Risk & Governance Market are Palo Alto Networks (US), Microsoft (US), Zscaler (US), Netskope (US), Cisco (US), IBM (US), ServiceNow (US), OneTrust (US), Forcepoint (US), Proofpoint (US), Credo AI (US), Holistic AI (UK), Mindgard (US), Cranium AI (US), NeuralTrust (Spain), ModelOp (US), Monitaur (US), Saidot (Finland), Relyance AI (US), Truyo (US), Airia (US), Trustible (US), HiddenLayer (US), Check Point (Israel), AI Shadow (US), Zenity (US), Noma Security (Israel), and Harmonic Security (US).

Shadow AI Risk & Governance Market - Investment & funding +Merger & Acquisition

Investment Funding Context

The Shadow AI Risk & Governance Market is attracting investment as vendors expand capabilities across AI discovery, governance, data protection, risk management, and agent security. Zenity raised USD 125 million in Series C funding in August 2026, bringing its total funding to approximately USD 185 million, to accelerate its AI agent security platform and global expansion. Airia secured USD 100 million in funding in September 2025 to expand its AI governance, security, and orchestration capabilities for enterprises. ModelOp raised USD 10 million in Series B funding in August 2024 to expand its AI governance software, portfolio intelligence, and automated governance capabilities. These investments indicate increasing investor interest in specialized platforms addressing AI visibility, governance, security, and control requirements.

Revenue Shift Context

The Shadow AI Risk & Governance Market is evolving toward integrated platforms that bring multiple control functions together across enterprise AI environments. Spending is expanding beyond basic AI discovery toward governance and policy management, data protection and security controls, risk and compliance management, and AI access and agent governance. Solutions remain the primary offering, while services are gaining importance as organizations require support for implementation, integration, risk assessments, policy development, testing, assurance, and managed governance. This shift is creating opportunities for vendors that can combine multiple governance and security capabilities within a unified enterprise architecture.

Mergers and Acquisitions

Mergers and acquisitions in the Shadow AI Risk & Governance Market are increasingly focused on adding AI security, identity, access management, asset visibility, and governance capabilities to broader enterprise technology portfolios. Recent transactions involving Palo Alto Networks, ServiceNow, and Armis reflect growing consolidation as established technology and cybersecurity providers expand their capabilities across AI applications, data, identities, and connected assets. These developments are contributing to the integration of AI governance with broader security and risk-management platforms.

SHADOW AI RISK & GOVERNANCE MARKET: MERGERS AND ACQUISITIONS, JANUARY 2024–SEPTEMBER 2026

Company Revenue Share Details

The Shadow AI Risk & Governance Market remains highly fragmented, with the top five players collectively accounting for approximately 13.8% of total market revenue. The competitive landscape includes diversified technology and cybersecurity providers such as Cisco, Microsoft, Zscaler, Palo Alto Networks, ServiceNow, and IBM, alongside specialized vendors such as Tuya, Airia, Mindgard, NeuralTrust, Credo AI, ModelOp, and Zenity. Established providers are extending their broader security, data, identity, and enterprise technology platforms to address AI governance requirements, while specialized vendors focus on AI discovery, governance, data protection, risk assessment, AI security, and agent controls. The remaining market is distributed across numerous emerging and specialized providers, reflecting the fragmented nature of the market and the coexistence of diversified technology companies, cybersecurity platforms, and dedicated AI governance and security vendors.

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
prn_302889440
Press Eligible
Yes
Press Eligible Reason
Business technology market report covering AI governance, cybersecurity, enterprise adoption, funding, and M&A.
Source Name
Shadow AI Risk &amp; Governance Market worth $8.64 billion by 2032
Original Summary

<p>DELRAY BEACH, Fla., Sept. 25, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Shadow AI Risk & Governance Market is projected to grow from USD 1.39 billion in 2026 to USD 8.64 billion by 2032 at a CAGR of 35.6% during the forecast period. Browse 400 market data Tables and 50...</p>

Image URL
https://mmx.prnewswire.com/media/MS1173081/MarketsandMarkets-Logo.jpg?id=OA2969410&p=facebook
Content Hash (SHA-256, erste 32 hex)
2dbc85c17f4781c0cf3f32348a298af6
A Lasting Legacy: Honoring GreenPath Founder Albert O. Horner
Image File
Original HTML

FARMINGTON HILLS, Mich., Sept. 25, 2026 /PRNewswire/ -- GreenPath Financial Wellness honors the life and legacy of founder Albert O. Horner, who passed away on September 5th, 2026, at the age of 100. Mr. Horner's vision to change lives laid the foundation for what would become one of the nation's leading nonprofit financial wellness organizations, helping millions of people achieve financial freedom and stability over its 65-year history.

The organization began in the early 1960s as a credit counseling service established through the Michigan Credit Union League. Under Mr. Horner's leadership, it grew into an accredited nonprofit dedicated to helping individuals and families overcome financial challenges and achieve their goals. Mr. Horner served as the President and CEO of GreenPath, originally known as Credit Counseling Centers, for more than 30 years, from 1961 until his retirement in 1997.

Mr. Horner was among the early pioneers of financial counseling, believing that people facing financial hardship deserve compassionate guidance and practical solutions. Helping others navigate and recover from debt and financial stress was Mr. Horner's passion and life's work, and his vision remains central to GreenPath's mission.

"Albert Horner believed financial challenges shouldn't define a person's future and that everyone who comes to us deserves dignity, compassion, and practical support," said Kristen Holt, President and CEO of GreenPath Financial Wellness. "He understood the shame and stigma that can accompany financial hardship and built GreenPath to help people find a path forward without judgment. While we mourn his passing, we celebrate an extraordinary legacy that continues to guide our mission and lives on in every person and family we help."

Today, GreenPath's impact can be measured by the lives transformed through the organization's services. In 2025 alone, the nonprofit provided 121,739 financial counseling services and helped clients repay more than $282 million in debt.

As GreenPath honors Mr. Horner's life and contributions, the organization remains dedicated to the mission he began decades ago: empowering people to lead financially healthy lives.

About GreenPath Financial Wellness

GreenPath Financial Wellness is a trusted, national nonprofit on a mission to empower people to lead financially healthy lives. Founded in 1961 and headquartered in Farmington Hills, Michigan, GreenPath offers free financial counseling with NFCC- and HUD-certified experts. If you're struggling to budget, manage debt, or reach your financial goals, you're not alone. Contact GreenPath at (866) 648-8122 or visit www.greenpath.com.

For press and media inquiries, please contact:

Audrey Downs

Communications Manager

[email protected]

SOURCE GreenPath Financial Wellness

Share this article

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
prn_302890319
Press Eligible
Yes
Press Eligible Reason
QA FAIL (need review): Final paragraph is a generic About-the-company boilerplate (company description, location, and services) with no news context, rather than a news-specific closing or natural summary of the event.
Source Name
A Lasting Legacy
Original Summary

<p>FARMINGTON HILLS, Mich., Sept. 25, 2026 /PRNewswire/ -- GreenPath Financial Wellness honors the life and legacy of founder Albert O. Horner, who passed away on September 5th, 2026, at the age of 100. Mr. Horner's vision to change lives laid the foundation for what would become one of the...</p>

Image URL
https://mmx.prnewswire.com/media/MS1782328/GreenPath-Financial-Wellness.jpg?id=OA2971300&p=facebook
Content Hash (SHA-256, erste 32 hex)
fdc8716f83d5d17bf144982425c215ce
Liquid Handling System Market worth $7.79 billion by 2031 - Exclusive Report by MarketsandMarkets™
Image File
Original HTML

DELRAY BEACH, Fla., Sept. 25, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Liquid Handling System Market is projected to reach USD 7.79 billion by 2031 from USD 5.26 billion in 2026, at a CAGR of 8.2% during the forecast period.

Browse 250 market data Tables and 55 Figures spread through 300 Pages and in-depth TOC on 'Liquid Handling System Market- Global Forecast to 2031'

Liquid Handling System Market Size & Forecast:

- Market Size Available for Years: 2026–2031

- 2026 Market Size: USD 5.26 billion

- 2031 Projected Market Size: USD 7.79 billion

- CAGR (2026–2031): 8.2%

Liquid Handling System Market Trends & Insights:

- By region, the Asia Pacific market is expected to register the highest CAGR during the forecast period.

- By type, the automated systems is expected to register the highest CAGR of 9.0% during the forecast period.

- By product, the pipettes segment is expected to register the highest CAGR of 9.5% during the forecast period.

- By application, the genomics segment is expected to grow at the highest CAGR of 9.0% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=192124302

Globally, pipettes are experiencing steady growth within the liquid handling systems market, supported by increasing laboratory automation, high-throughput screening, and the expansion of pharmaceutical, biotechnology, genomics, and clinical research activities. Growth in pipettes will be driven particularly by electronic and smart pipetting technologies, integration with laboratory information systems (LIMS), digital data logging, programmable dispensing, and compatibility with automated workflows. The growing use of genomics, personalized medicine, cell and gene therapy, drug discovery, and high-throughput screening is driving demand for multi-channel, highly precise pipettes that can handle low-volume samples. In addition, miniaturization is driving demand for nanoliter-scale liquid handling, while replacement of older manual equipment with ergonomic and electronic models is supporting recurring demand. Asia Pacific is expected to provide significant growth opportunities as laboratory automation and biotechnology infrastructure expand across emerging markets.

By type, the automated systems segment accounted for the largest share of the liquid handling systems market in 2025.

By type, the liquid handling systems market is segmented into automated, electronic, and manual systems. The automated systems segment held the largest share of the liquid handling market in 2025. The automated systems segment of the global liquid handling systems market is experiencing increasing adoption, driven by the growing demand for laboratory automation, high-throughput processing, precision, reproducibility, and operational efficiency. Pharmaceutical and biotechnology laboratories are increasingly shifting from manual liquid transfer to robotic and fully automated platforms for repetitive processes such as pipetting, dispensing, dilution, sample preparation, and microplate handling. Technological advancements, including AI and machine learning, sensor-based liquid-level detection, low-volume dispensing, modular and scalable platforms, and integration with LIMS and other laboratory instruments, are further enhancing system capabilities. Adoption is also expanding across genomics, drug discovery, molecular diagnostics, cell-based assays, and personalized medicine, while growing sustainability requirements are encouraging the development of systems that minimize reagent consumption, dead volume, and plastic waste.

By product, the pipettes segment accounted for a significant share of the liquid handling systems market in 2025.

By product, the liquid handling systems market is segmented into pipettes (semi-automated pipettes, manual pipettes, and electronic pipettes), consumables (disposable tips, tubes & plates, reagent containers, and other consumables), liquid handling workstations (semi-automated systems and fully automated systems), burettes, accessories (microplate reagent dispensers and microplate washers), software & services (maintenance, installation, and calibration services and training & education services), and other products. The pipette systems segment held the largest share of the liquid handling market in 2025. The pipettes segment is seeing growing adoption globally, supported by rising demand for laboratory automation, high-throughput workflows, and precise liquid handling across pharmaceutical, biotechnology, genomics, diagnostics, and research applications. Laboratories are increasingly shifting from conventional single-channel manual pipettes toward electronic and multi-channel pipetting solutions to improve accuracy, repeatability, processing efficiency, and user convenience. The expanding use of pipettes in PCR, genomics, drug discovery, cell-based assays, and microplate-based workflows is further driving demand for advanced pipetting technologies that can handle multiple samples efficiently and support increasingly complex laboratory processes.

By application, the drug discovery segment accounted for a significant share of the liquid handling systems market in 2025.

By application, the liquid handling systems market is segmented into drug discovery (high-throughput screening, compound weighing & dissolution, ADME screening, and other drug discovery applications), clinical diagnostics (sample preparation, ELISA, and other clinical diagnostic applications), genomics (genotyping, next-generation sequencing, polymerase chain reaction (PCR), DNA/RNA purification, gene expression analysis, and other genomics applications), proteomics, cell & gene therapy, forensic testing, environmental testing (water analysis, wastewater analysis, and other environmental testing applications), food testing, and other applications. The drug discovery segment held the largest share of the liquid handling systems market in 2025. The drug discovery application is witnessing increasing adoption of liquid handling systems, driven by the growing demand for high-throughput screening (HTS), automated compound management, and precise assay preparation across pharmaceutical and biotechnology laboratories. Liquid handling platforms are increasingly being utilized for compound dispensing, serial dilution, reagent addition, sample preparation, and assay plate preparation, enabling researchers to process large compound libraries with greater speed, accuracy, and reproducibility. The adoption of miniaturized assays, nanoliter dispensing, acoustic liquid handling, and integrated robotic workflows is further enhancing screening efficiency while reducing reagent consumption. In addition, integration with microplate readers, imaging systems, LIMS, and advanced data-analysis platforms is improving workflow traceability and supporting more efficient hit identification and lead optimization processes.

By end user, the hospitals & diagnostic laboratories segment dominated the liquid handling systems market in 2025.

By end user, the liquid handling systems market is segmented into hospitals & diagnostic laboratories, biotechnology & pharmaceutical companies, research & academic institutes, forensic laboratories, the food & beverage industry, environmental testing laboratories, and other end users. The hospitals & diagnostic laboratories segment held the largest share of the liquid handling systems market in 2025. Hospitals & diagnostic laboratories are increasingly adopting liquid handling systems to improve sample processing efficiency, accuracy, and workflow standardization amid rising diagnostic testing volumes. The growing use of molecular diagnostics, immunoassays, genomics, PCR-based testing, and clinical chemistry is driving demand for automated solutions for pipetting, sample preparation, aliquoting, dilution, and reagent dispensing. Laboratories are also shifting toward automated, integrated liquid-handling platforms that connect with analyzers, LIS/LIMS, barcode systems, and other laboratory equipment, improving sample traceability and reducing manual errors. In addition, the need to shorten turnaround times, minimize sample contamination, optimize reagent use, and reduce repetitive manual workloads is driving greater adoption of robotic and scalable liquid handling systems, particularly in high-volume hospitals and centralized diagnostic laboratories.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=192124302

The Asia Pacific is expected to register the highest growth rate in the anatomic pathology market during the forecast period.

The anatomic pathology market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific is projected to grow at the highest CAGR from 2026 to 2031. China, Japan, and India are the primary growth markets within the region. Japan's well-established healthcare infrastructure, growing cancer burden, and increasing adoption of digital pathology technologies continue to support market expansion. China's healthcare modernization initiatives are driving investments in pathology laboratories, cancer diagnostic services, and advanced tissue analysis technologies across healthcare institutions. Meanwhile, India's rapidly expanding network of tertiary-care hospitals, cancer centers, and diagnostic laboratories is increasing the adoption of automated pathology workflows and advanced diagnostic solutions to support rising disease diagnosis volumes. North America held the largest regional share in 2025, supported by its mature pathology infrastructure, widespread adoption of advanced diagnostic technologies, strong presence of leading market participants, and established utilization of histopathology, cytopathology, and biomarker testing across clinical practice.

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
prn_302889228
Press Eligible
Yes
Press Eligible Reason
Substantive market forecast and industry analysis for liquid handling systems, laboratory automation, and life sciences professionals.
Source Name
Liquid Handling System Market worth $7.79 billion by 2031
Original Summary

<p>DELRAY BEACH, Fla., Sept. 25, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Liquid Handling System Market is projected to reach USD 7.79 billion by 2031 from USD 5.26 billion in 2026, at a CAGR of 8.2% during the forecast period. Browse 250 market data Tables and 55 Figures...</p>

Image URL
https://mmx.prnewswire.com/media/MS1173081/MarketsandMarkets-Logo.jpg?id=OA2969061&p=facebook
Content Hash (SHA-256, erste 32 hex)
f8821f6b879195c1cda0448bd3ebaace
Wriggle Box LLC Launches Indiegogo Campaign for 'Wriggleworm,' a Breakthrough Full-Body Sensory Regulation Play Structure
Image File
Original HTML

Wriggle Box LLC Launches Indiegogo Campaign for 'Wriggleworm,' a Breakthrough Full-Body Sensory Regulation Play Structure

Designed for autistic individuals, neurodivergent children, and sensory seekers, the innovative play structure combines gentle, full-body mild-to-moderate or deep pressure input with physical exertion to promote self-regulation and calm.

NORTH LAS VEGAS, Nev., Sept. 25, 2026 /PRNewswire/ -- Wriggle Box LLC today announced the official launch of its Indiegogo crowdfunding campaign for Wriggleworm, a novel sensory regulation play structure engineered to provide soothing, full-body mild-to-moderate or deep pressure input paired with beneficial physical movement.

Inspired by a simple yet powerful premise—What is the greatest full-body sensory experience a person can have? —the Wriggleworm was developed to mimic the sensation of digging through the earth as a worm does, offering calming, uniform pressure from all sides as the user moves through it.

Unlike traditional sensory squeeze tools or compression tubes, Wriggleworm combines tactile and proprioceptive feedback with active physical exertion. This dual-action approach aids sensory regulation, decreases anxiety, and promotes focus for autistic individuals, children with ADHD, sensory processing differences, and anyone who benefits from sensory-based movement.

Key Features & Benefits:

- Full-Body Sensory Input: Delivers mild-to-moderate or deep, even pressure across the entire body as users maneuver through the structure.

- Integrated Physical Exertion: Encourages gross motor play and physical movement, turning sensory therapy into an engaging play experience.

- Designed for Regulation: Helps users self-regulate when overwhelmed, providing a safe and controlled output for excess energy.

- Inclusive & Purpose-Built: Created with input and inspiration directly from the neurodivergent community to address unmet sensory needs in homes, schools, and therapy centers.

"Sensory regulation is essential for wellbeing, yet many existing tools only engage one part of the body or lack the dynamic movement required to achieve true calm," said Adrian Krosnick, Founder of Wriggle Box LLC. "The Wriggleworm bridges that gap by turning deep-pressure sensory therapy into a fun, full-body experience that empowers users to self-regulate on their own terms."

The Indiegogo campaign offers early backers exclusive rewards and early-bird pricing to help bring the first production run of Wriggleworm to homes, occupational therapy clinics, and classrooms nationwide.

To learn more about Wriggleworm or support the campaign, visit the Indiegogo campaign page here: https://www.indiegogo.com/en/projects/wigglebox/wriggleworm

Wriggle Box LLC is a mission-driven company dedicated to designing functional, joyful, and inclusive sensory solutions for autistic and neurodivergent individuals, sensory seekers, and occupational therapy professionals.

Name: Adrian Krosnick Title: Founder Company: Wriggle Box LLC Email: [email protected]Phone: 1-702-659-9419 Website/Campaign: https://www.indiegogo.com/en/projects/wigglebox/wriggleworm Media Kit / Images: https://youtu.be/xDviFJ4k3b4?si=eSAinRzcXR3ToZL6

SOURCE Wriggle Box LLC

Share this article

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
prn_302890345
Press Eligible
Yes
Press Eligible Reason
Company product launch and crowdfunding campaign for a sensory regulation structure targeting therapy centers, schools, and professional users.
Source Name
Unknown Company
Original Summary

<p>Designed for autistic individuals, neurodivergent children, and sensory seekers, the innovative play structure combines gentle, full-body mild-to-moderate or deep pressure input with physical exertion to promote self-regulation and calm. NORTH LAS VEGAS, Nev., Sept. 25, 2026 /PRNewswire/...</p>

Image URL
https://mmx.prnewswire.com/media/MS1996470/Wriggleworm-in-different-settings.jpg?id=OA2971135&p=facebook
Content Hash (SHA-256, erste 32 hex)
4dc88d1894b06c25e859d96eb6a3ea85
2026 IMS | Updated FUMANBA-1 Analysis of IASO Bio's FUCASO Reveals That In Vivo Durable Persistence of CAR-T cells Is Associated with Sustained MRD Negativity and Delayed Disease Progression
Original HTML

2026 IMS | Updated FUMANBA-1 Analysis of IASO Bio's FUCASO Reveals That In Vivo Durable Persistence of CAR-T cells Is Associated with Sustained MRD Negativity and Delayed Disease Progression

At 2026 IMS: Updated FUMANBA-1 Data from IASO Bio's Equecabtagene Autoleucel (Fucaso) Demonstrate In Vivo Durable Persistence of CAR-T Cells Associated with Sustained MRD-Negativity and Delayed Disease Progression

— Retrospective analysis of 102 patients from the pivotal FUMANBA-1 study who had achieved MRD negativity: durable in vivo persistence of FUCASO CAR-T cells (assessed by peripheral blood vector copy number) was associated with sustained MRD negativity and prolonged time to progression — median VCN persistence of 463 days in sustained MRD-negative patients versus 272 days in patients with MRD conversion

— Patients with del(17p), high tumor burden, and rapidly progressive disease were more prone to early CAR-T cell clearance and MRD conversion; the findings are hypothesis-generating and may inform strategies to prolong CAR-T cell persistence and the use of CAR-T therapy in earlier lines of treatment

SHANGHAI and NANJING, China, and PLEASANTON, Calif., Sept. 25, 2026 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of novel cell therapies and biologics for hematologic malignancies and autoimmune diseases announced that results from a retrospective analysis of FUMANBA-1 — the pivotal registration study of its world's first fully human BCMA-targeting CAR-T cell therapy product, FUCASO (equecabtagene autoleucel injection, Eque-cel) — were presented as a poster at the 2026 International Myeloma Society (IMS) Annual Meeting[1] (Abstract No.: PA-469). The results showed that durable persistence of FUCASO CAR-T cells in patients (assessed by vector copy number [VCN] in peripheral blood) was associated with sustained minimal residual disease (MRD) negativity and prolonged time to progression (TTP); moreover, patients with del(17p), high tumor burden, and rapidly progressive disease features were more prone to early CAR-T cell clearance and MRD conversion.

Study Design: A Retrospective Analysis Focused on "MRD Conversion"

Clinical follow-up data have shown that FUCASO can induce deep MRD negativity in patients with relapsed/refractory multiple myeloma (R/R MM), but some patients experience MRD conversion after achieving MRD negativity. To explore the potential mechanisms underlying MRD conversion and to provide hypothesis-generating evidence for optimizing full-course management following CAR-T cell infusion, this retrospective analysis enrolled 102 patients from the FUMANBA-1 study who had achieved MRD negativity. Based on whether MRD conversion occurred during follow-up, patients were divided into a sustained MRD-negative group (n=61) and an MRD-conversion group (n=41), and baseline characteristics as well as peripheral blood vector copy number (VCN) persistence (with the event defined as peripheral blood VCN below the lower limit of detection) were analyzed for both groups. VCN persistence was assessed using the Kaplan-Meier method and unadjusted Cox regression; the hierarchical correlations among time to progression (TTP), duration of MRD negativity, and VCN persistence were assessed using Kendall's tau-b coefficient. All analyses were hypothesis-generating in nature.

Patients with MRD Conversion Had Higher-Risk Baseline Features and Shorter VCN Persistence

The analysis showed that patients who experienced MRD conversion presented with higher-risk, more rapidly progressive baseline disease characteristics: a higher proportion with del(17p) (26.8% vs 13.1%), a higher proportion of patients with bone marrow plasma cells ≥50% (26.8% vs 11.5%), a shorter median interval from diagnosis to enrollment (31.1 months vs 54.0 months), and a higher proportion receiving bridging therapy (61.0% vs 41.0%). Regarding VCN persistence, median VCN persistence was 272 days in the MRD-conversion group versus 463 days in the sustained MRD-negative group, a difference of approximately 191 days (HR 0.73, 95% CI 0.42–1.26, P=0.2568). Although the sustained MRD-negative group showed a numerical VCN persistence advantage of approximately 191 days, this difference is not sufficient to draw a statistically significant conclusion given the statistical power of the current data.

Correlation analyses revealed a consistent benefit chain of "VCN persistence — sustained MRD negativity — delayed progression": time to progression (TTP) was strongly correlated with duration of MRD negativity (tau-b=0.736, P0.0001); time to progression (TTP) was moderately correlated with VCN persistence (tau-b=0.306, P0.0001); and VCN persistence was correlated with duration of MRD negativity (tau-b=0.185, P=0.006).

Conclusion

This analysis suggests that more durable in vivo persistence of FUCASO CAR-T cells is associated with sustained MRD negativity and prolonged time to progression (TTP), supporting peripheral blood VCN persistence as a candidate pharmacodynamic (PD) marker of durable disease control; patients with del(17p), high tumor burden, and rapidly progressive disease are more prone to early CAR-T cell clearance and MRD conversion. These findings are hypothesis-generating in nature and may inform strategies to prolong CAR-T cell persistence as well as the use of CAR-T therapy in earlier lines of treatment.

Professor Lugui Qiu

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences

"We are very pleased to report this follow-up analysis of FUMANBA-1 focusing on MRD conversion at this year's IMS Annual Meeting, and the results are encouraging. MRD negativity is an important hallmark of deep response, yet some advanced patients still experience MRD conversion after achieving MRD negativity — an issue of long-standing clinical focus. This analysis suggests that durable in vivo persistence of CAR-T cells may be one of the key factors in maintaining long-term MRD negativity and delaying disease progression; patients with high-risk cytogenetic features and high tumor burden are more prone to early CAR-T cell clearance and MRD conversion. These hypothesis-generating findings point the way for research into strategies to prolong cell persistence, and also support clinical exploration of the value of CAR-T therapy at earlier stages of disease."

SOURCE IASO Bio

Share this article

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
prn_302890352
Press Eligible
Yes
Press Eligible Reason
Biopharmaceutical company research presented at a medical meeting, reporting clinical data on CAR-T cell persistence and multiple myeloma outcomes.
Source Name
Unknown Company
Original Summary

<p>At 2026 IMS: Updated FUMANBA-1 Data from IASO Bio's Equecabtagene Autoleucel (Fucaso) Demonstrate In Vivo Durable Persistence of CAR-T Cells Associated with Sustained MRD-Negativity and Delayed Disease Progression — Retrospective analysis of 102 patients from the pivotal FUMANBA-1 study...</p>

Content Hash (SHA-256, erste 32 hex)
29f0dd90b1a40c9ff8dcb80ef8a6a947
Acron Aviation Extends Thales Singapore Authorized Repair Center to Cover ACSS's Surveillance Products
Image File
Original HTML

New in-region capability expands aftermarket support for Asia-Pacific operators and MROs

ST. PETERSBURG, Fla., Sept. 25, 2026 /PRNewswire/ -- Acron Aviation today announced a five-year extension of its Authorized Repair Center (ARC) agreement with Thales Singapore, which supports its ACSS surveillance product line. Operating from Singapore, the facility will serve operators and MROs across the Asia-Pacific region.

Under the extended agreement, Thales Singapore will continue to perform repair and overhaul on all ACSS surveillance products, including T3CAS, establishing in-region capability for customers previously served from outside Asia-Pacific.

"Singapore gives us the right footprint, and Thales is the right partner," said Ronald Nye, President, Avionics at Acron Aviation. "Extending that relationship to surveillance puts local presence behind more of our products and gives our customers in-region technical support."

"With ACSS's large market share for surveillance products in Asia, Thales will leverage its strategic presence in Singapore to deliver the highest standards of service, reliability and performance," said Thomas Mouveaux, General Manager APAC for Aviation Global Services at Thales. "Thales is proud to be the only Acron Aviation authorized repair partner for Surveillance products in the Asia-Pacific region."

About Acron Aviation

Acron Aviation is strategically aligned to deliver world-leading commercial aviation solutions designed to serve aircraft operators and airframe manufacturers across the globe. Our expertise extends to multiple facets of commercial aviation, from OEM certified avionics — including surveillance, displays, recorders, thermal switches, and market-leading flight data analytics — to aftermarket support. With a global footprint, we are uniquely positioned to deliver comprehensive, cutting-edge solutions that enhance our customers' operations. Acron Aviation is a member of the Acron Technologies platform of specialized companies that innovate to create safer skies and protect lives. For more information, visit acronaviation.com and acrontechnologies.com.

SOURCE Acron Aviation

Share this article

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
prn_302890347
Press Eligible
Yes
Press Eligible Reason
Corporate aviation announcement about extending an authorized repair partnership and regional aftermarket support for operators and MROs.
Source Name
Unknown Company
Original Summary

<p>New in-region capability expands aftermarket support for Asia-Pacific operators and MROs ST. PETERSBURG, Fla., Sept. 25, 2026 /PRNewswire/ -- Acron Aviation today announced a five-year extension of its Authorized Repair Center (ARC) agreement with Thales Singapore, which supports its ACSS...</p>

Image URL
https://mmx.prnewswire.com/media/MS1884730/Acron-Technologies-Logo.jpg?id=OA2971336&p=facebook
Content Hash (SHA-256, erste 32 hex)
853046a16329ac137404a8680556d37d